TP53 and neoplasm: To investigate whether miR-339-5p inhibits tumor cell migration and invasion through the activation of p53, chamber transwell assays were employed to determine the effects of miR-339-5p on the abilities of cell migration and invasion in HCT116 p53+/+ and p53−/− cells.